Mitchell Stephen Ray
Vanda Pharmaceuticals Inc. · Director
Mitchell Stephen Ray is listed in filings as Director at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA). The current snapshot covers public activity from Nov 18, 2024 to Jun 8, 2026. Reported amounts are shown as $32.1K to $25.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $32k7k shares | SellJun 13, 2025 | $4.59 | $5.45 |